IFP Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22
Closed -$332 4624
2024
Q3
$332 Sell
22
-610
-97% -$9.23K ﹤0.01% 3176
2024
Q2
$8.96K Buy
+632
New +$8.55K ﹤0.01% 2377
2023
Q1
Sell
-2,240
Closed -$41K 3859
2022
Q4
$41K Buy
2,240
+45
+2% +$652 ﹤0.01% 2369
2022
Q3
$41K Buy
2,195
+46
+2% +$687 ﹤0.01% 2521
2022
Q2
$40K Hold
2,149
﹤0.01% 2316
2022
Q1
$40K Buy
+2,149
New +$37K ﹤0.01% 2316
2019
Q1
$135K Sell
7,960
-3,275
-29% -$56.5K 0.02% 587
2018
Q4
$171K Sell
11,235
-1,815
-14% -$32K 0.01% 926
2018
Q3
$266K Buy
13,050
+441
+3% +$8.77K 0.01% 928
2018
Q2
$237K Buy
12,609
+602
+5% +$11.3K 0.01% 982
2018
Q1
$236K Hold
12,007
0.01% 915
2017
Q4
$236K Buy
12,007
+498
+4% +$9.97K 0.01% 918
2017
Q3
$247K Buy
11,509
+597
+5% +$12.7K 0.01% 1019
2017
Q2
$228K Sell
10,912
-16
-0.1% -$323 0.01% 1051
2017
Q1
$212K Buy
10,928
+1,225
+13% +$22.7K 0.01% 1087
2016
Q4
$165K Buy
9,703
+372
+4% +$6.53K 0.01% 1152
2016
Q3
$175K Buy
9,331
+3,106
+50% +$58.5K 0.01% 1059
2016
Q2
$107K Sell
6,225
-1,735
-22% -$32K 0.01% 1300
2016
Q1
$135K Sell
7,960
-4,355
-35% -$79.1K 0.02% 587
2015
Q4
$291K Buy
+12,315
New +$306K 0.02% 681

Other funds holding HQL

IFP Advisors's HQL Position: Q4 2024 in Review

IFP Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 22 shares — an estimated $332 sold.

IFP Advisors first reported a position in HQL in Q4 2015 and held it in 20 quarters. The position peaked at $291K in Q4 2015. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.

  • IFP Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
  • IFP Advisors sold 22 abrdn Life Sciences Investors shares in Q4 2024, an estimated $332.
  • IFP Advisors first reported a position in abrdn Life Sciences Investors in Q4 2015 and held it in 20 quarters.
  • IFP Advisors's abrdn Life Sciences Investors position peaked at $291K in Q4 2015.
  • 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.

Based on IFP Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.